Biotech

All Articles

Genentech to close cancer cells immunology investigation team

.Genentech will close its cancer immunology research study department, and unit head and popular tis...

Kezar drops solid lump but to show its own worth in phase 1 test

.Kezar Lifestyle Sciences is actually dropping its unpromising stage 1 sound cyst drug as the biotec...

Acelyrin goes down izokibep, drops 3rd of staff

.Despite izokibep maintaining its newly found winning touch in the medical clinic, Acelyrin is no lo...

Rivus' period 2 obesity-related cardiac arrest test hits endpoint

.Rivus Pharmaceuticals has actually plumped up the customers of its fat-busting, muscle-sparing medi...

Ovid halts preclinical work, IV program after soticlestat fall short

.Ovid Therapy already revealed final month that it was actually trimming its own headcount as the bu...

Eli Lilly opens up $700M nucleic acid R&ampD facility in Boston ma Seaport

.Eli Lilly has actually opened up a $700 thousand R&ampD center in the Boston ma Port, enhancing its...

Boundless Bio produces 'reasonable' discharges 5 months after $100M IPO

.Just five months after getting a $100 million IPO, Vast Bio is actually giving up some employees as...

Halda's $126M is going to accelerate 'secure and also get rid of' tumor medications

.The initial phases of oncology R&ampD may not be short of interesting new methods, as well as Halda...

Lykos 'remorses' certainly not revealing study infractions along with publisher

.Psychopharmacology has pulled 3 write-ups concerning midstage medical test information examining Ly...

Analysts dig into Avidity's DMD win, exposing subtleties in records

.Avidity Biosciences satisfied real estate investors with phase 1/2 data in Duchenne muscle dystroph...